Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M V Kirova"'
Autor:
A I Parfenov, O V Akhmadullina, E A Sabelnikova, N I Belostotsky, M V Kirova, S G Khomeriki, S V Bykova
Publikováno v:
Терапевтический архив, Vol 89, Iss 4, Pp 45-52 (2017)
Aim. To elucidate the role of intestinal carbohydrases (glucoamylase, maltase, sucrose, and lactase) in the etiology and pathogenesis of functional bowel diseases (FBD). Subjects and methods. 74 patients (36 men and 38 women) aged 18 to 50 years with
Externí odkaz:
https://doaj.org/article/96aa352ccf2c4456b2babfe70b47ae59
Autor:
O V Knyazev, A V Kagramanova, I N Ruchkina, N A Fadeeva, A A Lishchinskaya, O N Boldyreva, E Yu Zhulina, P L Shcherbakov, N V Orlova, M V Kirova, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 89, Iss 2, Pp 20-27 (2017)
Aim. To evaluate the efficacy and safety of adalimumab (ADA) in patients with Crohn’s disease (CD) treated at the Department of Inflammatory Bowel Diseases, Moscow Clinical Research and Practical Center, and to determine the predictors of a therapy
Externí odkaz:
https://doaj.org/article/0b5d77866b324af1bbbd51c41b9389ca
Autor:
S V Bykova, E A Sabelnikova, R B Gudkova, V N Drozdov, P L Shcherbakov, M V Kirova, S G Khomeriki, G G Varvanina, A A Belyaeva, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 88, Iss 2, Pp 39-43 (2016)
Aim. To determine celiac disease detection rate in patients with digestive disease. Subjects and methods. A total of 318 gastroenterological patients admitted to be treated at the Central Research Institute of Gastroenterology in September to October
Externí odkaz:
https://doaj.org/article/d150cc1415b246aabe6ea660c22310b0
Confocal laser endomicroscopy in the diagnosis of colorectal diseases: image interpretation criteria
Autor:
P. L. Shcherbakov, M. V. Kirova
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 6, Pp 744-750 (2016)
Confocal laser endomicroscopy is a rapidly emerging area of gastroenterology that bridges endoscopy and histological examination. This newest technique has enabled endoscopists to assess the microstructure of gastrointestinal mucosa in vivo during th
Externí odkaz:
https://doaj.org/article/b61a4436987b48afadb94624a5aae012
Autor:
S G Khomeriki, S V Bykova, A I Parfenov, E A Sabel'nikova, N. I. Belostoskij, M V Kirova, O. V. Ahmadullina
Publikováno v:
Clinical Medicine (Russian Journal). 96:365-370
The aim of the study was to show the importance of intestinal carbohydrase (glucoamylase, maltase, sucrase and lactase) in the etiology and pathogenesis of functional bowel diseases. Material and methods. It was examined 74 patients with FBD in age f
Autor:
S G Khomeriki, A I Parfenov, E A Sabel'nikova, O V Akhmadullina, S V Bykova, M V Kirova, N I Belostotsky
Publikováno v:
Терапевтический архив, Vol 89, Iss 4, Pp 45-52 (2017)
To elucidate the role of intestinal carbohydrases (glucoamylase, maltase, sucrose, and lactase) in the etiology and pathogenesis of functional bowel diseases (FBD).74 patients (36 men and 38 women) aged 18 to 50 years with FBD were examined. Accordin
Autor:
E.Yu. Zhulina Zhulina, P L Shcherbakov, Oleg Knyazev, O N Boldyreva, N A Fadeeva, M V Kirova, A I Parfenov, A V Kagramanova, I N Ruchkina, N V Orlova, A A Lishchinskaya
Publikováno v:
Терапевтический архив, Vol 89, Iss 2, Pp 20-27 (2017)
To evaluate the efficacy and safety of adalimumab (ADA) in patients with Crohn's disease (CD) treated at the Department of Inflammatory Bowel Diseases, Moscow Clinical Research and Practical Center, and to determine the predictors of a therapy respon
Autor:
E A Sabel'nikova, A I Parfenov, M V Kirova, Belyaeva Aa, Shcherbakov Pl, R B Gudkova, S V Bykova, Drozdov Vn, Varvanina Gg, S G Khomeriki
Publikováno v:
Терапевтический архив, Vol 88, Iss 2, Pp 39-43 (2016)
To determine celiac disease detection rate in patients with digestive disease.A total of 318 gastroenterological patients admitted to be treated at the Central Research Institute of Gastroenterology in September to October 2012 were examined. The pat
Autor:
N V Orlova, A I Parfenov, Oleg Knyazev, M V Kirova, N. A. Fadeeva, A V Kagramanova, O N Boldyreva
Publikováno v:
Journal of Clinical Practice. 6:15-23
Now in Russia registered two biological drugs for the treatment of UC is infliximab and golimumab. The largest experience with the use of infliximab (IFX) shows that, despite the high efficiency, in some patients the IBD (20-30%) will develop acquire
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (2)
The article describes the diffuse esophageal spasm which is not amenable to conservative treatment.